Sean Ellis Entera Bio Ltd. (ENTX) insider trading activity

Sean Ellis is Director of Entera Bio Ltd.. Currently has a direct ownership of 134,727 shares of ENTX, which is worth approximately $295,052. The most recent transaction as insider was on Jan 15, 2025, when has been sold 7,100 shares (Ordinary Shares, par value NIS 0.0000769 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 135K

5.56% 3M change

31.96% 12M change

Total Value Held $295,052

Sean Ellis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 15 2025	BUY Grant, award, or other acquisition	-	7,100 Added 5.01%	134,727 Ordinary Shares, par v...
Oct 02 2024	BUY Grant, award, or other acquisition	-	7,466 Added 5.53%	127,627 Ordinary Shares, par v...
Aug 27 2024	BUY Grant, award, or other acquisition	-	18,061 Added 13.07%	120,161 Ordinary Shares, par v...
Aug 21 2023	BUY Open market or private purchase	$24,000 $0.6 p/Share	40,000 Added 28.15%	102,100 Ordinary Shares, par v...
Nov 11 2022	BUY Open market or private purchase	$15,900 $0.53 p/Share	30,000 Added 32.57%	62,100 Ordinary Shares, par v...
Jul 21 2022	BUY Open market or private purchase	$24,436 $1.64 p/Share	14,900 Added 31.7%	32,100 Ordinary Shares, par v...
Jan 18 2022	BUY Open market or private purchase	$28,100 $2.81 p/Share	10,000 Added 50.0%	10,000 Ordinary Shares, par v...

Sean Ellis

Director

Jerusalem, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTX shares.

Notify only if

Value

Insider Trading

Get notified when an Entera Bio Ltd. insider buys or sells ENTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Entera Bio Ltd.

Track Activities on ENTX

Account